Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1095121


Analgesics - A Worldwide Market Intelligence Report


Description: An aging baby boomer population and subsequent rise in geriatric population, and rising therapeutic benefits of pain treatment drugs (internal) are major factors driving growth in the global analgesics market. Expanding number of surgical procedures, and longer life of patients suffering from chronic illnesses such as cancer and AIDS further contribute to increased demand for analgesics. The market is characterized by the presence of a large number of patent-expired products.

Dynamics of the pain management drugs market witnessed significant changes in recent years. The failure of several drugs, considered initially as promisingly curative including recent unsuccessful COX-2 inhibitors, prompted manufacturers and researchers to undertake more research programs. There is a lucrative market for effective analgesics, which do not cause any adverse side effects.

These and other market data and trends are presented in "Analgesics: A Worldwide Market Intelligence Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.


Contents: 1. METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level

2. GLOBAL ANALGESICS MARKET OVERVIEW
Pain Therapeutic Market
Analgesics Market - Offering Immense Potential
Liquid Analgesics Register Rapid Growth
Neuropathic Pain - Unexplored
Ibuprofen Scoring High
External Analgesics - In a slump
Boom in Demand for Topical Analgesic Patches

3. PRODUCT FACTS
1. Internal Analgesics
Aspirin
Acetaminophen
Ibuprofen
Others (includes combination drugs)
2. External Analgesics
Combination Analgesics

4. MARKET TRENDS
Escalating R&D Costs: A Boon or Bane?
Cox II Crisis Tarnishes Industry Growth
Novel Therapies to Propel Opioid and Non-Opioid Therapies
Rx-to-OTC Switch
Why Consumers Prefer OTC Drugs?
Development of Analgesic Tripeptides

5. CORPORATE DEVELOPMENTS
Bayer to Acquire Sagmel’s OTC Business
E5 Pharma Receives Approval from FDA
Pharmaceutical Associates Receives Approval from FDA
Concord Receives New Drug Approvals
Hisamitsu Receives Approval for SALONPAsÒ
Johnson & Johnson Submits NDA to FDA
Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural
Akela Extends Agreement with Janssen
Daiichi and Lead Chemical Receives Approval for LoxoninÒ Tape
Tokio Marine Capital to Acquire Showa Yakuhin Kako
Corgenix Collaborates with Randox Laboratories
Corgenix Receives EPO Approval for Aspirin Resistance Method
IOL to Expand Production Capacity
American Oriental Bioengineering Partners with China Aoxing
Abraxis Takes Over Shimoda and its Subsidiary Company
ProEthic Pharmaceuticals Releases Ibudone for Acute Pain
Management
Dr. Reddy’s Laboratories Introduces Supanac for Acute Pain
Management
PLx Initiates Clinical Trial For Aspirin-PC
Ranbaxy Receives Approval from FDA
Wockhardt Receives FDA Approval for DPN + APAP
Alpharma to Market Flector® Patch in the US
Auriga and Mikart Inks Agreement to Market Codein
Watson Receives FDA Approval for Oxycodone Hydrochloride and
Ibuprofen
Labopharm’s Tramadol Receives Approval in Canada
Lion Acquires BUFFERIN® Trademark Rights
Grunenthal’s Extends Licensing Agreement with Ortho-McNeil
China Aoxing Pockets LRT
Anesiva Inks Joint Venture Agreement Wanbang
Beijing Med-Pharm Inks Agreement with Lotus Healthcare
LAB International Inks Licensing Agreement with Janssen
Pharmaceutica
Three Sixty Pockets Rockford-Montgomery Labs
Antares Enters into License and Development Agreement for
Opioid Analgesic
Neurodiscovery Receives Approval for NSL-101 Phase II
Clinical Trials
Mallinckrodt Introduces Magnacet™ Tablets for Pain Management
Wockhardt to Launch New Painkiller
Paladin Labs and Labopharm Introduce Tridural™
Shionogi & Co Introduces OxiNorm Powder 0.5%

6. MAJOR PLAYERS
Bayer Consumer Care (USA)
Bristol-Myers Squibb Company (USA)
Johnson & Johnson (USA)
McNeil Consumer Healthcare (Canada)
Novartis International AG (Switzerland)
Pfizer Inc. (USA)
Reckitt Benckiser Group Plc (UK)
Sanofi Aventis (France)
Wyeth (USA)
Wyeth Consumer Healthcare

7. MARKET ANALYTICS

8. THE UNITED STATES
Pain Statistics in the US
Industry Overview
Internal Analgesics
Cox-2 Drugs in for Some Trouble
Switch to OTC Drugs
Promotional Strategies for the Internal Analgesics
Pediatric Analgesics: The New Kid on the Block
External Analgesics
Stretching Boundaries
Rubs, Patches: Driving the External Analgesics Market
Patch Relief Gaining Momentum

9. CANADA

10. JAPAN

11. EUROPE
European Pain Management Market
Generics Restrain Revenue Growth

a. France

b. Germany

c. The United Kingdom

d. Italy

e. Spain

f. Rest of Europe

12. ASIA-PACIFIC
The OTC Analgesic Market
Comparison of Major Regions for OTC Analgesics Market in
Asia-Pacific - 2004
Aspirin - The Chinese Market

13. LATIN AMERICA

14. REST OF WORLD

EXHIBITS

Table 1: Market Shares of Opioid/ Acetaminophen Combination
Products in the Opioid Script Volume

Table 2: Global Analgesics Market by Region for the Period
2007-2015 (Sales in US$ Million)

Table 3: Percentage Breakdown of Global Analgesics Market by
Region for the Years 2008 & 2012

Table 4: Global Internal Analgesics Market by Region for the
Period 2007-2015 (Sales in US$ Million)

Table 5: Percentage Breakdown of Global Internal Analgesics
Market by Region for the Years 2008 & 2012

Table 6: Global Internal Analgesics Market by Segment for the
Period 2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown of Global Internal Analgesics
Market by Segment for the Years 2008 & 2012

Table 8: Global Aspirin Market by Region for the Period
2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown of Global Aspirin Market by
Region for the Years 2008 & 2012

Table 10: Global Acetaminophen Market by Region for the
Period 2007-2015 (Sales in US$ Million)

Table 11: Percentage Breakdown of Global Acetaminophen Market
by Region for the Years 2008 & 2012

Table 12: Global Ibuprofen Market by Region for the Period
2007-2015 (Sales in US$ Million)

Table 13: Percentage Breakdown of Global Ibuprofen Market by
Region for the Years 2008 & 2012

Table 14: Global Other Internal Analgesics Market by Region
for the Period 2007-2015 (Sales in US$ Million)

Table 15: Percentage Breakdown of Global Other Internal
Analgesics Market by Region for the Years 2008 & 2012

Table 16: Global External Analgesics by Region for the Period
2007-2015 (Sales in US$ Million)

Table 17: Percentage Breakdown of Global External Analgesics
by Region for the Years 2008 & 2012

Table 18: Market Shares of Top Ten Brands in the US Internal
Tablet Analgesics Market - 2007

Table 19: Market Shares of Top Ten Brands in the US Internal
Liquid Analgesics Market - 2007

Table 20: Market Shares of Retail Distribution Channels for
Internal Analgesics in the US - 2008E

Table 21: Market Shares of Retail Distribution Channels for
Internal Liquid Analgesics in the US - 2008E

Table 22: Market Shares of Top Ten Brands in the US External
Analgesics Market - 2007

Table 23: Market Shares of Retail Distribution Channels for
External Analgesics in the US - 2008E

Table 24: Analgesics Market by Segment in US: 2007-2015 (Sales
in US$ Million)

Table 25: Percentage Breakdown of Analgesics Market by Segment
in US for the Years 2008 & 2012

Table 26: Analgesics Market by Segment in Canada: 2007-2015
(Sales in US$ Million)

Table 27: Percentage Breakdown of Analgesics Market by Segment
in Canada for the Years 2008 & 2012

Table 28: Market Shares of Leading OTC Analgesics
Manufacturers in Japan - 2005

Table 29: Analgesics Market by Segment in Japan: 2007-2015
(Sales in US$ Million)

Table 30: Percentage Breakdown of Analgesics Market by Segment
in Japan for the Years 2008 & 2012

Table 31: Market Shares of Popular Brands in the European
Pain & Inflammation Medication Market - 2004

Table 32: Analgesics Market by Region in Europe: 2007-2015
(Sales in US$ Million)

Table 33: Percentage Breakdown of Analgesics Market by Region
in Europe for the Years 2008 & 2012

Table 34: Analgesics Market by Segment in Europe: 2007-2015
(Sales in US$ Million)

Table 35: Percentage Breakdown of Analgesics Market by Segment
in Europe for the Years 2008 & 2012

Table 36: Market Shares of Leading Analgesics Manufacturers in
France - 2005

Table 37: Analgesics Market by Segment in France: 2007-2015
(Sales in US$ Million)

Table 38: Percentage Breakdown of Analgesics Market by Segment
in France for the Years 2008 & 2012

Table 39: Market Shares of Leading Analgesics Manufacturers in
Germany - 2005

Table 40: Analgesics Market by Segment in Germany: 2007-2015
(Sales in US$ Million)

Table 41: Percentage Breakdown of Analgesics Market by Segment
in Germany for the Years 2008 & 2012

Table 42: Market Shares of Leading Analgesics Manufacturers in
the UK - 2005

Table 43: Analgesics Market by Segment in UK: 2007-2015 (Sales
in US$ Million)

Table 44: Percentage Breakdown of Analgesics Market by Segment
in UK for the Years 2008 & 2012

Table 45: Market Shares of Leading Analgesics Manufacturers in
Italy - 2005

Table 46: Analgesics Market by Segment in Italy: 2007-2015
(Sales in US$ Million)

Table 47: Percentage Breakdown of Analgesics Market by Segment
in Italy for the Years 2008 & 2012

Table 48: Market Shares of Leading Analgesics Manufacturers in
Spain - 2005

Table 49: Analgesics Market by Segment in Spain: 2007-2015
(Sales in US$ Million)

Table 50: Percentage Breakdown of Analgesics Market by Segment
in Spain for the Years 2008 & 2012

Table 51: Analgesics Market by Segment in Rest of Europe:
2007-2015 (Sales in US$ Million)

Table 52: Percentage Breakdown of Analgesics Market by Segment
in Rest of Europe for the Years 2008 & 2012

Table 53: Analgesics Market by Segment in Asia-Pacific:
2007-2015 (Sales in US$ Million)

Table 54: Percentage Breakdown of Analgesics Market by Segment
in Asia- Pacific for the Years 2008 & 2012

Table 55: Analgesics Market by Segment in Latin America:
2007-2015 (Sales in US$ Million)

Table 56: Percentage Breakdown of Analgesics Market by Segment
in Latin America for the Years 2008 & 2012

Table 57: Analgesics Market by Segment in Rest of World:
2007-2015 (Sales in US$ Million)

Table 58: Percentage Breakdown of Analgesics Market by Segment
in Rest of World for the Years 2008 & 2012

COMPANIES PROFILED


Companies Mentioned - Bayer Consumer Care (USA) - Bristol-Myers Squibb Company (USA) - Johnson & Johnson (USA) - McNeil Consumer Healthcare (Canada) - Novartis International AG (Switzerland) - Pfizer Inc. (USA) - Reckitt Benckiser Group Plc (UK) - Sanofi Aventis (France) - Wyeth (USA) - Wyeth Consumer Healthcare


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1095121

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 12:40:41
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Analgesics - A Worldwide Market Intelligence Report
Web Address:
http://www.researchandmarkets.com/reports/1095121
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,651.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 12:40:41

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)